The closing of a Fort Dodge plant in 2014 will eliminate nearly 100 jobs, though many of those employees could still find work within the company.
Boehringer (BOH-ringer) Ingelheim Vetmedica spokeswoman Cory Sullivan says officials recently decided to gradually remove production from the plant after pharmaceutical giant Pfizer opted to shift work away from the facility.
Sullivan says about 90 percent of the work done at the plant is manufacturing Pfizer products.
But the company is preparing to expand its research capabilities at its main Fort Dodge facility. The Messenger in Fort Dodge says that expansion will yield nearly 60 new jobs.
Sullivan also says the company hopes the majority of the workers at plant set for closure can transfer to another facility.
___
Information from: The Messenger, http://www.messengernews.net